About Pherecydes Pharma
Pherecydes Pharma is a company based in Romainville (France) founded in 2006.. Pherecydes Pharma has raised $16.4 million across 6 funding rounds from investors including GO CAPITAL, European Union and ACE Management. Pherecydes Pharma offers products and services including Live Draw Sydney, Data Sydney, and Betting Services. Pherecydes Pharma operates in a competitive market with competitors including Paratek Pharma, Spero Therapeutics, Cempra, Bugworks Research and Locus Biosciences, among others.
- Headquarter Romainville, France
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.4 M (USD)
in 6 rounds
-
Latest Funding Round
$56.62 K (USD), Grant
Dec 31, 2021
-
Investors
GO CAPITAL
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pherecydes Pharma
Pherecydes Pharma offers a comprehensive portfolio of products and services, including Live Draw Sydney, Data Sydney, and Betting Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Real-time streaming of Sydney lottery results for users.
Platform providing historical and current Sydney lotto results.
Online tools for lottery betting and predictions.
Unlock access to complete
Unlock access to complete
Funding Insights of Pherecydes Pharma
Pherecydes Pharma has successfully raised a total of $16.4M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $56.62 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $56,620
-
First Round
First Round
(01 Jun 2007)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Grant - Pherecydes Pharma | Valuation |
investors |
|
| Nov, 2018 | Amount | Grant - Pherecydes Pharma | Valuation |
investors |
|
| Jan, 2018 | Amount | Series B - Pherecydes Pharma | Valuation | GO CAPITAL |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pherecydes Pharma
Pherecydes Pharma has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include GO CAPITAL, European Union and ACE Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pherecydes Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pherecydes Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pherecydes Pharma Comparisons
Competitors of Pherecydes Pharma
Pherecydes Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Paratek Pharma, Spero Therapeutics, Cempra, Bugworks Research and Locus Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for antimicrobial resistant infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for drug-resistant bacterial infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical-stage pharmaceutical company focused on developing antibacterials
|
|
| domain | founded_year | HQ Location |
Drugs for antibiotic-resistant infections and cancer are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for infectious disease and inflammatory indications
|
|
| domain | founded_year | HQ Location |
Therapies for multi-drug resistant infections are developed using bacteriophages.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pherecydes Pharma
Frequently Asked Questions about Pherecydes Pharma
When was Pherecydes Pharma founded?
Pherecydes Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Pherecydes Pharma located?
Pherecydes Pharma is headquartered in Romainville, France. It is registered at Romainville, Ile-de-france, France.
Is Pherecydes Pharma a funded company?
Pherecydes Pharma is a funded company, having raised a total of $16.4M across 6 funding rounds to date. The company's 1st funding round was a Series B of $10.6M, raised on Jun 01, 2007.
What does Pherecydes Pharma do?
Pherecydes Pharma is a French, early-stage biotech developing bacteriophage treatments against multi-drug resistant bacterial infections. The main bacteria they are targeting include E.coli and P. aeruginosa which are common, and fatal, infections in burn victims. Their phage therapy clinical trial, phase III for burn victims, called PHAGOBURN was funded by the European Govt. (EUR 3.85 M). in Jun.2015, they launched the project PNEUMOPHAGE, targeted at developing phage therapies for acute respiratory infections ventilator-acquired pneumonia caused by P. aeruginosa. Since Jan.2015, they are part of the PHOSA project aimed at developing phage treatments for Diabetic Foot Ulcers and Bone Joint infections, caused by staphylococci species.
Who are the top competitors of Pherecydes Pharma?
Pherecydes Pharma's top competitors include Spero Therapeutics, Melinta Therapeutics and Vedanta Biosciences.
What products or services does Pherecydes Pharma offer?
Pherecydes Pharma offers Live Draw Sydney, Data Sydney, and Betting Services.
Who are Pherecydes Pharma's investors?
Pherecydes Pharma has 11 investors. Key investors include GO CAPITAL, European Union, ACE Management, Ace management solutions, and EIC Fund.